A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists

Clinical Drug Investigation

Volumn 16, Issue 1, 1998, Pages 53-61

  Lapeyre Mestre, Maryse ^a   Desboeuf, Karine ^a   Aptel, Isabelle ^a   Chale, Jean Jacques ^a   Montastruc, Jean Louis ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; ARTICLE; DEPRESSION; DRUG INFORMATION; DRUG USE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HUMAN; INSOMNIA; MEDICAL EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; QUESTIONNAIRE;

EID: 0031878690     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816010-00007     Document Type: Article

References (20)

1. Montastrue JL, Llau ME, Schmitt L, et al. Ordonnance du psychiatre, ordonnance du généraliste: approche pharmacoépidémiologique. Psychol Medicate 1995: 27 Special 2: 118-21
2. Nau JY. Consumption of psychotropics in France. Lancet 1994; 343: 1152
3. Gerard PE, Dagens V, Deslandes A. 1960-2000: 40 ansd'utilisation des antidépresseurs. Sem Hôp Paris 1995; 71: 727-34
4. Cialdella PH, Figon G, Boissel JP. Information thérapeutique et intention de prescription: une élude auprès de 117 médecins généralistes français de la région rhône-alpes. In: Fondation Marcel Nériuex, editor. Pharmacoépidémiologie. prescription cl utilisation des médicaments. 1992 Cinquiémes entretiens du Centre Jacques Cartier. Montréal
5. Isacsson G, Redfars I, Wasserman D, et al. Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. BMJ 1994; 309: 1546-9
6. Song F, Frecmantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683-7
7. Owens D. Benefits of new drugs are exaggerated. BMJ 1994; 309: 1281-2
8. Anderson IM. Tomenson BM. The efficacy of selective scrotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238-49
9. Anderson IM. Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyelic antidepressants: a meta-analysis. BMJ 1995; 310: 1433-8
10. Montgomery SA, Kasper S, Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995: 9: 33-40
11. Henry JA, Alexander CA, Sener EK, Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221-4
12. Mackay FJ, Dunn NR, Wilton LV, et al. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf 1997; 6: 235-46
13. Sporer KA. The serotonin syndrome: implicated drugs, pathophysiology and management. Drug Saf 1995; 13: 94-105
14. Oolfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrist. Am J Psychiatry 1993; 150: 571-7
15. Rouillon F, Blachier C, Dreyfus JP, et al. Etude pharmacoépidémiologique de la consommation des antidépresseurs en population générale. Encéphale 1996; 22: S39-S48
16. Anonyme. Benzodiazepines-antidépresseurs: un couple difficile. Med Hyg 1994; 52: 1496
17. Medawar C. The antidepressant web. Marketing depression and waking medicines work. Int J Risk Saf Med 1997; 10: 75-125
18. Paykel ES. Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992; 305: 1198-202
19. Kerr MP. Antidepressant prescribing: a comparison between general practitioners and psychiatrits. Br J Gen Pract 1994; 44: 275-6
20. Matthews K, Eagles JM, Matthews CA. The use of antidepressant drugs in general practice. A questionnaire survey. Eur J Clin Pharmacol 1993; 45: 205-10